Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Medicine|February 1, 2020
Primary anorectal malignant melanoma: A case reportXingdong Xu, Ting Ge, Gang WangJournal of the College of Physicians and Surgeons--Pakistan : JCPSP|August 31, 2018
Association between hOGG1 Polymorphisms and Pancreatic Cancer Susceptibility: A Meta-analysisXingdong Xu, Ting Ge, Gang WangMedicine|August 5, 2025
Hepatic inflammatory myofibroblastic tumor: A case report and literature reviewJinyu Liu, Gang Wang, Ting Ge, et al.Medicine|November 20, 2025
Primary pancreatic lymphoma masquerading as pancreatic carcinoma: A case report and literature reviewXingdong Xu, Tingting Zhang, Jinyu Liu, et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|October 7, 2023
Diagnostic Performance and Accuracy of Strain Elastography for BI-RADS Category 4 Lesions among Asian FemalesMeng Dong, Boyuan Xing, Bingyi Zhang, et al.Nanoscale|January 12, 2016
Light and cucurbit[7]uril complexation dual-responsiveness of a cyanostilbene-based self-assembled systemPengyao Xing, Hongzhong Chen, Mingfang Ma, et al.Angewandte Chemie (International Ed. in English)|September 21, 2017
Stable Oxindolyl-Based Analogues of Chichibabin's and Müller's HydrocarbonsJian Wang, Xingdong Xu, Hoa Phan, et al.Biochemical Pharmacology|May 11, 2019
Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growthBin Zhang, Mei Meng, Shufen Xiang, et al.Cell Death and Differentiation|March 8, 2020
The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapyBo Yang, Bin Zhang, Zhifei Cao, et al.Cell Death and Differentiation|April 7, 2020
Correction: The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapyBo Yang, Bin Zhang, Zhifei Cao, et al.Pageof 1